Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
Raphaèle Seror1, Simon J Bowman2, Pilar Brito-Zeron3
1Department of Rheumatology , Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hopitaux de Paris, Université Paris-Sud, INSERM U1012 , Le Kremlin Bicêtre , France.
The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) user guide clarifies scoring for clinicians. This aims to improve accurate assessment and reliable detection of treatment effects in primary SS patients.
Area of Science:
- Rheumatology
- Clinical Immunology
Background:
- The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a key tool for measuring disease activity in primary SS.
- Accurate and reproducible ESSDAI domain rating is crucial due to its use as a gold standard in clinical studies and trials.
- Challenges exist in consistently rating certain ESSDAI domains.
Purpose of the Study:
- To provide a comprehensive user guide for the ESSDAI.
- To offer detailed definitions and clarifications for rating each ESSDAI domain.
- To introduce minor score improvements reflecting advancements in understanding SS manifestations.
Main Methods:
- Development of a user guide with precise definitions for ESSDAI domains.
- Inclusion of updated knowledge on Sjögren's syndrome disease manifestations.
- Guidance on rating specific ESSDAI domains to enhance clarity.
Main Results:
- The user guide aims to improve clinician understanding and application of the ESSDAI.
- Enhanced clarity in ESSDAI domain rating is expected to increase reliability.
- The guide facilitates better detection of true treatment-related changes over time.
Conclusions:
- This ESSDAI user guide enhances the assessment of primary SS patients.
- Improved ESSDAI appraisal, alongside defined activity levels and minimal clinically important change, aids treatment effectiveness demonstration.
- The guide promotes consistent and reliable disease activity measurement in primary SS.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome III : Nursing Management
Rheumatic Heart Disease I: Introduction

